STOCK TITAN

Halozyme to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Halozyme Therapeutics, Inc. (NASDAQ: HALO) will be participating in upcoming investor conferences with Nicole LaBrosse, the Chief Financial Officer, presenting and hosting investor meetings. The company will be at The Citizens JMP Life Sciences Conference on May 14, 2024, and the Benchmark 2024 Healthcare House Call Virtual Conference on May 21 and May 22, 2024. The presentations will be available via live audio webcasts on the Company's Investor Relations section.

Positive
  • None.
Negative
  • None.

SAN DIEGO, May 8, 2024 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Nicole LaBrosse, Chief Financial Officer, is scheduled to present and host investor meetings at the following investor conferences:

Event:




The Citizens JMP Life Sciences Conference

Format:




Fireside Chat and 1x1 Meetings

Presentation Date:




Tuesday, May 14, 2024

Presentation Time:




7:00 a.m. PT / 10:00 a.m. ET

Location:




New York, NY

 

Event:




Benchmark 2024 Healthcare House Call Virtual Conference

Format:




1x1 Meetings

Date:




Tuesday, May 21 and Wednesday, May 22, 2024

A live audio webcast of the JMP presentation will be available on the Investor Relations section of the Company's website. Replays of the audio webcasts will be available for 90 days following the conference.

About Halozyme

Halozyme is a biopharmaceutical company advancing disruptive solutions to improve patient experiences and outcomes for emerging and established therapies. As the innovators of ENHANZE® drug delivery technology with the proprietary enzyme rHuPH20, Halozyme's commercially-validated solution is used to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of reducing treatment burden for patients. Having touched more than 800,000 patient lives in post-marketing use in seven commercialized products across more than 100 global markets, Halozyme has licensed its ENHANZE® technology to leading pharmaceutical and biotechnology companies including Roche, Takeda, Pfizer, Janssen, AbbVie, Eli Lilly, Bristol-Myers Squibb, argenx, ViiV Healthcare, Chugai Pharmaceutical and Acumen Pharmaceuticals.

Halozyme also develops, manufactures and commercializes, for itself or with partners, drug-device combination products using its advanced auto-injector technologies that are designed to provide commercial or functional advantages such as improved convenience, reliability and tolerability, and enhanced patient comfort and adherence. The Company has two commercial proprietary products, Hylenex® and XYOSTED®, partnered commercial products and ongoing product development programs with several pharmaceutical companies including Teva Pharmaceuticals and Idorsia Pharmaceuticals.

Halozyme is headquartered in San Diego, CA and has offices in Ewing, NJ and Minnetonka, MN. Minnetonka is also the site of its operations facility.

For more information visit www.halozyme.com and connect with us on LinkedIn and Twitter.

Contacts:
Tram Bui
VP, Investor Relations and Corporate Communications
609-359-3016
tbui@halozyme.com

Samantha Gaspar
Teneo
212-886-9356
samantha.gaspar@teneo.com

 

Halozyme Therapeutics, Inc. Logo. (PRNewsFoto/Halozyme Therapeutics, Inc.) (PRNewsfoto/Halozyme Therapeutics, Inc.)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/halozyme-to-participate-in-upcoming-investor-conferences-302139420.html

SOURCE Halozyme Therapeutics, Inc.

FAQ

When will Halozyme be participating in upcoming investor conferences?

Halozyme will be participating in The Citizens JMP Life Sciences Conference on May 14, 2024, and the Benchmark 2024 Healthcare House Call Virtual Conference on May 21 and May 22, 2024.

Who will be presenting and hosting investor meetings for Halozyme at the conferences?

Nicole LaBrosse, the Chief Financial Officer, will be presenting and hosting investor meetings for Halozyme at the upcoming conferences.

Where can the live audio webcasts of the presentations be accessed?

The live audio webcasts of the presentations can be accessed on the Investor Relations section of Halozyme's website.

For how long will the replays of the audio webcasts be available following the conferences?

Replays of the audio webcasts will be available for 90 days following the conferences.

Halozyme Therapeutics, Inc.

NASDAQ:HALO

HALO Rankings

HALO Latest News

HALO Stock Data

6.74B
127.27M
1.11%
99.2%
7.31%
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
United States of America
SAN DIEGO